Registered number
11546759
CVPMedical Limited
Filleted Accounts
30 September 2025
CVPMedical Limited
Registered number: 11546759
Balance Sheet
as at 30 September 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 2,318 604
Current assets
Cash at bank and in hand 217,709 137,216
Creditors: amounts falling due within one year 4 (30,417) (26,457)
Net current assets 187,292 110,759
Net assets 189,610 111,363
Capital and reserves
Called up share capital 100 100
Profit and loss account 189,510 111,263
Shareholders' funds 189,610 111,363
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
C Plakogiannis
Director
Approved by the board on 2 December 2025
CVPMedical Limited
Notes to the Accounts
for the year ended 30 September 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Fixtures, fittings, tools and equipment over 5 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 2 2
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 October 2024 6,477
Additions 3,612
At 30 September 2025 10,089
Depreciation
At 1 October 2024 5,873
Charge for the year 1,898
At 30 September 2025 7,771
Net book value
At 30 September 2025 2,318
At 30 September 2024 604
4 Creditors: amounts falling due within one year 2025 2024
£ £
Taxation and social security costs 26,209 24,775
Other creditors 4,208 1,682
30,417 26,457
5 Other information
CVPMedical Limited is a private company limited by shares and incorporated in England. Its registered office is:
26 Grange Road
Geddington
Kettering
Northamptonshire
NN14 1AL
CVPMedical Limited 11546759 false 2024-10-01 2025-09-30 2025-09-30 VT Final Accounts April 2025 C Plakogiannis No description of principal activity 11546759 2023-10-01 2024-09-30 11546759 core:WithinOneYear 2024-09-30 11546759 core:ShareCapital 2024-09-30 11546759 core:RetainedEarningsAccumulatedLosses 2024-09-30 11546759 2024-10-01 2025-09-30 11546759 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 11546759 bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 11546759 bus:Director40 2024-10-01 2025-09-30 11546759 1 2024-10-01 2025-09-30 11546759 2 2024-10-01 2025-09-30 11546759 core:PlantMachinery 2024-10-01 2025-09-30 11546759 countries:England 2024-10-01 2025-09-30 11546759 bus:FRS102 2024-10-01 2025-09-30 11546759 bus:FilletedAccounts 2024-10-01 2025-09-30 11546759 2025-09-30 11546759 core:WithinOneYear 2025-09-30 11546759 core:ShareCapital 2025-09-30 11546759 core:RetainedEarningsAccumulatedLosses 2025-09-30 11546759 core:PlantMachinery 2025-09-30 11546759 2024-09-30 11546759 core:PlantMachinery 2024-09-30 iso4217:GBP xbrli:pure